These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34916609)

  • 21. JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit.
    Guo Z; Hu YH; Feng GS; Valenzuela Ripoll C; Li ZZ; Cai SD; Wang QQ; Luo WW; Li Q; Liang LY; Wu ZK; Zhang JG; Javaheri A; Wang L; Lu J; Liu PQ
    Acta Pharmacol Sin; 2023 Sep; 44(9):1777-1789. PubMed ID: 37186122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pristimerin protects against pathological cardiac hypertrophy through improvement of PPARα pathway.
    Lu Y; Zeng Z; Bao X; Wu M; Jing Z; Feng J
    Toxicol Appl Pharmacol; 2023 Aug; 473():116572. PubMed ID: 37269933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.
    Li XX; Zhang P; Yang Y; Wang JJ; Zheng YJ; Tan JL; Liu SY; Yan YM; Zhang YY; Cheng YX; Yang HT
    Acta Pharmacol Sin; 2022 Mar; 43(3):588-601. PubMed ID: 33967278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF-
    Li N; Sun W; Zhou X; Gong H; Chen Y; Chen D; Xiang F
    Biomed Res Int; 2019; 2019():1415809. PubMed ID: 31781591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
    Nalban N; Sangaraju R; Alavala S; Mir SM; Jerald MK; Sistla R
    Cardiovasc Toxicol; 2020 Jun; 20(3):235-248. PubMed ID: 31485892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Necrosis Factor-
    Yao R; Kong L; Yang C; Du J; Zhao G; Li Y
    Oxid Med Cell Longev; 2022; 2022():9469143. PubMed ID: 35528518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
    Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
    Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
    Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
    Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel polysaccharide from Acorus tatarinowii protects against LPS-induced neuroinflammation and neurotoxicity by inhibiting TLR4-mediated MyD88/NF-κB and PI3K/Akt signaling pathways.
    Zhong J; Qiu X; Yu Q; Chen H; Yan C
    Int J Biol Macromol; 2020 Nov; 163():464-475. PubMed ID: 32621930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
    Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
    PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
    Xiong Z; Sun G; Zhu C; Cheng B; Zhang C; Ma Y; Dong Y
    Eur J Pharmacol; 2010 Dec; 649(1-3):277-84. PubMed ID: 20863781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol Exerts Anti-Osteoarthritic Effect by Inhibiting TLR4/NF-κB Signaling Pathway via the TLR4/Akt/FoxO1 Axis in IL-1β-Stimulated SW1353 Cells.
    Xu X; Liu X; Yang Y; He J; Jiang M; Huang Y; Liu X; Liu L; Gu H
    Drug Des Devel Ther; 2020; 14():2079-2090. PubMed ID: 32581510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
    Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
    J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway.
    Yang H; Wang XX; Zhou CY; Xiao X; Tian C; Li HH; Yin CL; Wang HX
    J Cell Mol Med; 2020 Jun; 24(11):6233-6241. PubMed ID: 32343488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginkgolide A inhibits lipopolysaccharide-induced inflammatory response in human coronary artery endothelial cells via downregulation of TLR4-NF-κB signaling through PI3K/Akt pathway.
    Zhaocheng J; Jinfeng L; Luchang Y; Yequan S; Feng L; Kai W
    Pharmazie; 2016 Oct; 71(10):588-591. PubMed ID: 29441927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts.
    Cao T; Gao Z; Gu L; Chen M; Yang B; Cao K; Huang H; Li M
    PLoS One; 2014; 9(8):e103793. PubMed ID: 25099270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
    Ma SQ; Guo Z; Liu FY; Hasan SG; Yang D; Tang N; An P; Wang MY; Wu HM; Yang Z; Fan D; Tang QZ
    Acta Pharmacol Sin; 2021 Oct; 42(10):1575-1586. PubMed ID: 33462378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GPR30 Alleviates Pressure Overload-Induced Myocardial Hypertrophy in Ovariectomized Mice by Regulating Autophagy.
    Zhang S; Ma J; Wang X; Zhao D; Zhang J; Jiang L; Duan W; Wang X; Hong Z; Li Z; Liu J
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.